CUBIC-HV
LIVE

Serial Number

79303111

Owner

CUBICStars, Inc.

Attorney

R. Scott Keller

Filing Date

Oct 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CUBIC-HV Trademark

Serial Number: 79303111 • Registration: 6848730

CUBIC-HV is a trademark filed by CUBICStars, Inc. on October 26, 2020. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

CUBICStars, Inc.

1-1, Hyakunenkoen,
Kurume-shi Fukuoka 839-0864 , JP

Entity Type: 03

Trademark Details

Filing Date

October 26, 2020

Registration Date

September 20, 2022

Published for Opposition

July 5, 2022

Goods & Services

Analytical chemical agents for analysis in laboratories other than for medical or veterinary purposes; colored reagents kit comprising staining probes, namely, dyes, antibodies, DNA and RNA probes and specialized staining buffers for preparation of histological specimens or histopathological specimens for microscopic evaluation, other than for medical or veterinary use; coloring kit for making histological specimen or pathological specimens for microscopic evaluation consisting of chemical reagents other than for medical or veterinary purpose; chemical reagents, other than for medical or veterinary use; chemical agents for histological and pathological assays for scientific purposes, other than for medical or veterinary use; diagnostic reagents, other than for medical or veterinary use; analytical chemical agents for histological and pathological assays in laboratories, other than for medical or veterinary use; diagnostic reagents and preparations, other than for medical or veterinary use; reagents for scientific devices for chemical and biological analysis purposes; reagents for chemical analysis purposes other than for medical or veterinary purposes; chemical agents for histological and pathological scientific purposes other than for medical or veterinary purposes; chemical reagents for scientific purposes other than for medical or veterinary purposes; cell culture reagents for scientific or research purposes; antibody reagents for scientific purposes; reagents for scientific purposes; reagents for scientific use; biochemical preparations for scientific purposes; reagents for scientific or research use; reagents for research purposes; chemical reagents for paternity testing; chemical agents for use in manufacture of pharmaceuticals; in vitro diagnostic agents for scientific purposes; biochemical catalysts; biological preparations, other than for medical or veterinary use; chemicals for product development by biotechnology; penetrants for enhancing penetration of staining probes, namely, dyes, antibodies and DNA and RNA probes; chemical agents for histological and pathological staining, increasing signal-noise ratio and enhancing staining probe penetration; chemicals, namely, mixture of HEPES buffer, Triton X-100, NaCl, casein and screened penetrants; chemical reagents for non-medical purposes; reagents for protein examination and detection purposes, other than for medical or veterinary use; blocking reagents for bioassay purposes, other than for medical or veterinary use; stabilizing reagents for bioassay purposes, other than for medical or veterinary use; reagents for genetic research purposes, other than for medical or veterinary use; reagents and reagent chemicals for chemistry and research purposes, other than for medical or veterinary use; chemical reagents for scientific, research, or experimental purposes, other than for medical or veterinary use; reagents for scientific, experimental, and research purposes, other than for medical or veterinary use; reagents for detection of nucleic acid mutation, other than for medical or veterinary use; reagents for examination of proteins in specimens, other than for medical or veterinary use; reagents for examination of specific bacteria in specimens, other than for medical or veterinary use; reagents for detection or quantification of cells or cytoplasm, other than for medical or veterinary use; biochemical reagents, other than for medical use; protein analysis reagents, other than for medical or veterinary use; chemical reagents consisting of antibody kit for detection of particular protein, other than for medical or veterinary use; labeling reagents, other than for medical or veterinary use; chemical reagents for protein isolation, detection, measurement, and analysis purposes other than for medical or veterinary purpose; chemical reagents for scientific use, other than for medical or veterinary purpose; chemical reagents consisting of antibodies, other than for medical or veterinary purpose; chemical reagents for diagnosis using molecular sequences of extracts or analytes from or of organisms or biological substances such as nucleic acids, proteins, polypeptides, and antibodies, other than for medical or veterinary purpose; chemical reagents selected for research in life science field; laboratory reagents for use in molecular biology; biochemical reagents for use in molecular biology; chemical reagents for use in molecular biology and life science; molecular biological reagents for research purposes; reagents for test, examination, and research of pharmaceuticals, cosmetics, laboratory animals, human pathology specimen, or foods, other than for medical or veterinary use; staining reagents for research purposes, other than for medical or veterinary use; reagents and staining chemicals for preparation of histopathological specimens for research use; reagents and staining * chemical * agents for preparation of histopathological specimen for research use; staining chemicals and reagents for tissue specimens on microscope slides other than for medical or veterinary purpose; staining * chemical * agents and reagents for tissue specimens on microscope slides other than for medical or veterinary purpose; reagents for research and scientific purposes in histological and pathological fields, other than for medical or veterinary use; chemical reagents, biological reagents, cell lines reagents, cultured cells reagents, cell culture reagents, diagnostic chemicals, diagnostic and biological reagents, diagnostic and biological pharmaceuticals, and recombinant and natural proteins for diagnostic, scientific, industrial, experimental, and research purposes, for use in chemical, pharmaceutical, biotechnological, and diagnostic fields, other than for medical or veterinary use; reagents for chemistry, biology, biochemistry, immunology, and microbiology, and chemical agents for nucleic acid synthesis and analysis, other than for medical or veterinary use; reagents for scientific, experimental, or medical research, other than for medical or veterinary use; reagents for academic studies, administrative research, scientific research, and medical science research, other than for medical or veterinary use; chemical reagents for detection and visualization of nucleic acids or antibodies of biologically-derived materials on microscope slides for research or scientific purposes, other than for medical or veterinary use; diagnostic reagents for scientific or research purposes in oncological field, other than for medical or veterinary use; diagnostic reagents and chemical reagents, other than for medical or veterinary use; chemical agents and chemical reagents for use in field of research and engineering relating to biology or genetics, and chemicals for use in science and research, other than for medical or veterinary use; reagents for staining tissues and cells for scientific and research use; analytical samples and reagents for drug development and life science research, other than for medical or veterinary use; chemicals and chemical agents for manufacture of medicines and reagents, namely, HEPES buffer, Triton X-100, NaCl, casein and screened penetrants; chemical agents and reagents for detection of cancer diseases, tumor diseases, inflammatory conditions, infectious diseases, degenerative conditions, genetic abnormalities or genetic diseases, proliferative abnormalities or proliferative diseases, vascular diseases, precancerous conditions, malignant diseases, cancers, and congenital abnormalities for scientific or research purposes, other than for medical or veterinary use; reagents for pathological research, other than for medical or veterinary use; immunostaining reagents, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of protein in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of RNA in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of nucleic acid in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of nucleic acid mutation in physical chemistry or biology and somatology, other than for medical or veterinary use; reagents for test, assay, analysis, research, experiment, examination, and detection of cells and cytoplasm in physical chemistry or biology and somatology, other than for medical or veterinary use; chemical agents for use in RNA stabilization before and after purification in physicochemical experiments and medical tests; chemical reagents for experimental or research purposes; reagents for preparation and staining of tissue samples for processing for research; histology and cytology reagents and staining chemicals for preparation of histopathological specimens for research purposes, other than for medical or veterinary use; histology and cytology reagents and staining liquid for preparation of histopathological specimen for research purposes, other than for medical or veterinary use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 11, 2026 NREP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 31, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 30, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 28, 2023 ES7R
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 7, 2023 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 23, 2023 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 3, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 13, 2023 FICS
FINAL DISPOSITION PROCESSED
Jun 13, 2023 FIMP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 28, 2023 LIME
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2023 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 23, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2023 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 20, 2022 FICR
LIMITATION OF GOODS RECEIVED FROM IB
Oct 24, 2022 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 20, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 20, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 18, 2022 OPNX
NOTIFICATION PROCESSED BY IB
Jul 5, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 5, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 29, 2022 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 15, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 15, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 31, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 27, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 25, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 25, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 25, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 25, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 25, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2021 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 8, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 16, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 16, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 28, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 28, 2021 REPR